This study is testing two types of transcranial magnetic stimulation (TMS) – specifically, dorsal medial Prefrontal Cortex intermittent theta burst stimulation (iTBS) and continuous theta burst stimulation (cTBS) to the ROFC – for adolescents aged 13-17 with Obsessive-Compulsive Disorder (OCD). These adolescents have not found enough relief from other treatments. The main goals are to see if these TMS treatments are safe and well-tolerated by adolescents, and to understand any side effects. While TMS is approved for adults with OCD, this study will help us learn if it's a good option for younger people. The study aims to enroll 30 participants, but its current status is unclear.

Study design

This is a randomized, single-blind pilot study comparing two different TMS stimulation sites in 30 participants. It is an interventional study, meaning participants will receive a specific treatment.

What's involved

You would visit the clinic every weekday for 3 weeks (15 days) for TMS treatments. You will also have a brain MRI scan before and after treatments, and complete questionnaires.

Compensation

Not stated in the trial record.

Follow-up

Adverse events and completion rates will be measured from baseline to the completion of all protocol visits, up to 8 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.